PBH — Prestige Consumer Healthcare Inc.

Summary of PBH Q3 2026 Earnings Call

1. Key Financial Results and Metrics:

• Revenue: $283 million, slightly better than forecast but down 2.4% year-over-year (2.2% decline excluding FX).
• Gross Margin: 55.5%, consistent with expectations.
• Adjusted EPS: $1.14, down from $1.22 in the prior year.
• Free Cash Flow: $209 million year-to-date, up 13% from the previous year, with full-year guidance of $245 million or more.
• Net Debt: Approximately $1 billion, with a leverage ratio of 2.6 times.

2. Strategic Updates and Business Highlights:

• Successful management of supply chain challenges, particularly in the eye care category with Clear Eyes, which is seeing sequential improvement in supply.
• Acquisition of Pillar Five, enhancing control over the supply chain for eye care products.
• Diverse distribution channels helped offset declines in certain categories, particularly analgesics and cough/cold products.
• Continued strong performance in e-commerce, with over 10% growth in consumption in Q3.

3. Forward Guidance and Outlook:

• Narrowed full-year revenue outlook to approximately $1.1 billion.
• Anticipated adjusted diluted EPS of approximately $4.54 for the year.
• Expectation of continued sequential improvement in Clear Eyes supply through Q4 and into fiscal 2027.
• Confidence in long-term growth algorithm of 5% annual revenue growth despite current challenges.

4. Bad News, Challenges, or Points of Concern:

• Revenue decline attributed mainly to lower sales in eye and ear care due to supply constraints.
• Ongoing consumer volatility and headwinds in certain retail channels affecting order patterns.
• Concerns regarding the impact of a government shutdown and inflation on consumer behavior.
• A $10 million write-off related to a supplier loan due to the supplier's business shutdown, although this did not disrupt overall supply.

5. Notable Q&A Insights:

• Management noted a shift in consumer shopping patterns, with some retailers facing destocking while others are growing.
• Clear Eyes supply chain improvements are expected to continue, but full restocking may take time.
• E-commerce is growing, with marketing strategies evolving to better connect with consumers.
• The company remains focused on brand acquisitions for M&A rather than facility-related purchases.
• Management expressed confidence in their ability to navigate the current volatile environment and maintain a diversified business model.

Overall, while PBH faces challenges in certain product categories and supply chain issues, the company remains optimistic about its long-term growth prospects and strategic initiatives.